Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Pao

Showing results (21-30 of 202) with videos related to

Pageof 21
Sort By:
Nature Reviews. Clinical Oncology|August 21, 2013
Targeted therapies: Afatinib--new therapy option for EGFR-mutant lung cancerHelena A Yu, William Pao
Cancer Discovery|April 4, 2024
Elucidating the Cell Surfaceome to Accelerate Cancer Drug DevelopmentJacob B Geri, William Pao
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2011
T4 or MI?Salyka Sengsayadeth, Jay Montgomery, William Pao
The Journal of Molecular Diagnostics : JMD|July 29, 2005
Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomasQiulu Pan, William Pao, Marc Ladanyi
BMC Medical Genomics|February 21, 2014
Patterns and processes of somatic mutations in nine major cancersPeilin Jia, William Pao, Zhongming Zhao
The Journal of Pathology|December 3, 2010
Genetically informed lung cancer medicineWilliam Pao, A John Iafrate, Zengliu Su
The New England Journal of Medicine|October 22, 2005
Erlotinib in lung cancerWilliam Pao, Marc Ladanyi, Vincent A Miller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutationsYasushi Yatabe, William Pao, James R Jett
Proceedings of the American Thoracic Society|April 8, 2009
KRAS mutations in non-small cell lung cancerGregory J Riely, Jenifer Marks, William Pao
Cancer Journal (Sudbury, Mass.)|March 24, 2011
Molecular predictors of response to chemotherapy in non-small cell lung cancerJenny Andrews, Paul Yeh, William Pao, et al.
Pageof 21

Showing results (21-30 of 202) with videos related to

Sort By:
Pageof 21
Nature Reviews. Clinical Oncology|August 21, 2013
Targeted therapies: Afatinib--new therapy option for EGFR-mutant lung cancerHelena A Yu, William Pao
Cancer Discovery|April 4, 2024
Elucidating the Cell Surfaceome to Accelerate Cancer Drug DevelopmentJacob B Geri, William Pao
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 15, 2011
T4 or MI?Salyka Sengsayadeth, Jay Montgomery, William Pao
The Journal of Molecular Diagnostics : JMD|July 29, 2005
Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomasQiulu Pan, William Pao, Marc Ladanyi
BMC Medical Genomics|February 21, 2014
Patterns and processes of somatic mutations in nine major cancersPeilin Jia, William Pao, Zhongming Zhao
The Journal of Pathology|December 3, 2010
Genetically informed lung cancer medicineWilliam Pao, A John Iafrate, Zengliu Su
The New England Journal of Medicine|October 22, 2005
Erlotinib in lung cancerWilliam Pao, Marc Ladanyi, Vincent A Miller, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2012
Encouragement to submit data of clinical response to EGFR-TKIs in patients with uncommon EGFR mutationsYasushi Yatabe, William Pao, James R Jett
Proceedings of the American Thoracic Society|April 8, 2009
KRAS mutations in non-small cell lung cancerGregory J Riely, Jenifer Marks, William Pao
Cancer Journal (Sudbury, Mass.)|March 24, 2011
Molecular predictors of response to chemotherapy in non-small cell lung cancerJenny Andrews, Paul Yeh, William Pao, et al.
Pageof 21